Last reviewed · How we verify

NCT03541837: ESPCATHEART

Erector Spinae Plane Block and Pain Management in Cardiac Surgery

Completed NA Last updated 31 May 2018
What this trial tests

NA trial testing Ropivacaine in Cardiac Surgery in 40 participants. Completed in 1 March 2018.

Timeline
20 October 2017
Primary endpoint
25 February 2018
1 March 2018

Quick facts

Lead sponsorVinmec Healthcare System
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment40
Start date20 October 2017
Primary completion25 February 2018
Estimated completion1 March 2018
Sites1 location across Vietnam

Drugs / interventions tested

Conditions studied

Sponsor

Vinmec Healthcare System — full company profile →

Who can join

Adults 18 to 65, any sex, with Cardiac Surgery or Adult. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of the benefit effects of Peri-Operative analgesia by Continuous Bilateral Erector Spinae Plane block(ESP) for Open Cardiac Surgery: A case series prospective study with a comparison a retrospective case series (Before and after)

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Ropivacaine

Trials testing the same drug.

Other recruiting trials for Cardiac Surgery

Currently open trials in the same condition.

Other Vinmec Healthcare System trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03541837.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing